MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 318685 | Name: Saprisartan

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Saprisartan, also known as GR-138950 or GR-138950X, is an AT1 receptor antagonist. It is used for heart failure therapies and as an antihypertensive.

Chemical Structure

Saprisartan
Saprisartan
CAS#146623-69-0 (free)

Theoretical Analysis

MedKoo Cat#: 318685

Name: Saprisartan

CAS#: 146623-69-0 (free)

Chemical Formula: C25H22BrF3N4O4S

Exact Mass: 610.0497

Molecular Weight: 611.43

Elemental Analysis: C, 49.11; H, 3.63; Br, 13.07; F, 9.32; N, 9.16; O, 10.47; S, 5.24

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
146613-90-3 (potassium) 146623-69-0 (free)
Synonym
Saprisartan; GR-138950; GR 138950; GR138950; GR-138950X; Saprisartan potassium.
IUPAC/Chemical Name
3-[[3-bromo-2-[2-(trifluoromethylsulfonylamino)phenyl]-1-benzofuran-5-yl]methyl]-5-cyclopropyl-2-ethylimidazole-4-carboxamide
InChi Key
DUEWVPTZCSAMNB-UHFFFAOYSA-N
InChi Code
InChI=1S/C25H22BrF3N4O4S/c1-2-19-31-21(14-8-9-14)22(24(30)34)33(19)12-13-7-10-18-16(11-13)20(26)23(37-18)15-5-3-4-6-17(15)32-38(35,36)25(27,28)29/h3-7,10-11,14,32H,2,8-9,12H2,1H3,(H2,30,34)
SMILES Code
CCC1=NC(=C(N1CC2=CC3=C(C=C2)OC(=C3Br)C4=CC=CC=C4NS(=O)(=O)C(F)(F)F)C(=O)N)C5CC5
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 611.43 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Forhead AJ, Jellyman JK, Gillham K, Ward JW, Blache D, Fowden AL. Renal growth retardation following angiotensin II type 1 (AT₁) receptor antagonism is associated with increased AT₂ receptor protein in fetal sheep. J Endocrinol. 2011 Feb;208(2):137-45. doi: 10.1677/JOE-10-0360. Epub 2010 Nov 22. PubMed PMID: 21097994. 2: Charlton ST, Davis SS, Illum L. Evaluation of effect of ephedrine on the transport of drugs from the nasal cavity to the systemic circulation and the central nervous system. J Drug Target. 2007 Jun;15(5):370-7. PubMed PMID: 17541846. 3: Charlton ST, Davis SS, Illum L. Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems. Int J Pharm. 2007 Jun 29;338(1-2):94-103. Epub 2007 Feb 3. PubMed PMID: 17337137. 4: Charlton ST, Davis SS, Illum L. Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies. J Control Release. 2007 Apr 2;118(2):225-34. Epub 2006 Dec 23. PubMed PMID: 17261340. 5: Forhead AJ, Fowden AL. Role of angiotensin II in the pressor response to cortisol in fetal sheep during late gestation. Exp Physiol. 2004 May;89(3):323-9. Epub 2004 Mar 16. PubMed PMID: 15123568. 6: Forhead AJ, Broughton Pipkin F, Fowden AL. Effect of cortisol on blood pressure and the renin-angiotensin system in fetal sheep during late gestation. J Physiol. 2000 Jul 1;526 Pt 1:167-76. PubMed PMID: 10878109; PubMed Central PMCID: PMC2269992. 7: Timmermans PB. Pharmacological properties of angiotensin II receptor antagonists. Can J Cardiol. 1999 Nov;15 Suppl F:26F-8F. Review. PubMed PMID: 10579749. 8: Timmermans PB. Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeutics. Hypertens Res. 1999 Jul;22(2):147-53. Review. PubMed PMID: 10487332. 9: Wang J, Yi GH, Zhu SM, Gu AG, Popilskis S, Zhang H, Burkhoff D. The role of angiotensin II AT1 receptor in the maintenance of hemodynamics in a canine model of coronary microembolization-induced heart failure. J Cardiovasc Pharmacol. 1999 Feb;33(2):335-40. PubMed PMID: 10028945. 10: Anderson IK, Drew GM. The antihypertensive profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential homeostatic compensatory mechanisms in renal hypertensive rats. Br J Pharmacol. 1998 Nov;125(6):1236-46. PubMed PMID: 9863652; PubMed Central PMCID: PMC1565697. 11: Kuizinga MC, Smits JF, Arends JW, Daemen MJAP. AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction. J Mol Cell Cardiol. 1998 Feb;30(2):425-34. PubMed PMID: 9515019. 12: Ceiler DL, Nelissen-Vrancken HJ, De Mey JG, Smits JF. Effect of chronic blockade of angiotensin II-receptor subtypes on aortic compliance in rats with myocardial infarction. J Cardiovasc Pharmacol. 1998 Apr;31(4):630-7. PubMed PMID: 9554815. 13: Anderson IK, Drew GM. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950. Br J Pharmacol. 1997 Dec;122(7):1385-94. PubMed PMID: 9421286; PubMed Central PMCID: PMC1565088. 14: Abdi A, Johns EJ. The effect of angiotensin II receptor antagonists on kidney function in two-kidney, two-clip Goldblatt hypertensive rats. Eur J Pharmacol. 1997 Jul 23;331(2-3):185-92. PubMed PMID: 9274978. 15: Forhead AJ, Broughton Pipkin F, Sutherland MF, Fowden AL. Changes in the maternal and fetal renin-angiotensin systems in response to angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation. Exp Physiol. 1997 Jul;82(4):761-76. PubMed PMID: 9257117. 16: Hunt AA, Hilditch A, Drew GM. Effects of the angiotensin AT1 receptor antagonist GRI38950 on haemodynamic function in dogs. J Auton Pharmacol. 1997 Feb;17(1):1-11. PubMed PMID: 9201554. 17: Zhao L, al-Tubuly R, Sebkhi A, Owji AA, Nunez DJ, Wilkins MR. Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung. Br J Pharmacol. 1996 Nov;119(6):1217-22. PubMed PMID: 8937726; PubMed Central PMCID: PMC1915911. 18: Forhead AJ, Whybrew K, Hughes P, Broughton Pipkin F, Sutherland M, Fowden AL. Comparison of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation. Br J Pharmacol. 1996 Sep;119(2):393-401. PubMed PMID: 8886426; PubMed Central PMCID: PMC1915859. 19: Hilditch A, Prior HM, Drew GM. Further investigations into the mechanism of the antihypertensive activity of the angiotensin AT1 receptor antagonist, GR138950. Br J Pharmacol. 1996 Jun;118(3):711-9. PubMed PMID: 8762098; PubMed Central PMCID: PMC1909712. 20: Clark KL, Robertson MJ, Drew GM. Renal pharmacology of GR138950, a novel non-peptide angiotensin AT1 receptor antagonist. Eur J Pharmacol. 1995 Jul 4;280(2):195-203. PubMed PMID: 7589186.